Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heart Failure With Preserved Ejection Fraction Treated by Cardiac Resynchronisation Therapy Versus Rate Responsive Pacing: A Mechanistic Study

NCT03338374 is registered in ClinicalTrials.gov with Cardiff and Vale University Health Board as lead sponsor.

NCT NCT03338374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03338374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heart Failure With Preserved Ejection Fraction Treated by Cardiac Resynchronisation Therapy Versus Rate Responsive Pacing: A Mechanistic Study
Lead sponsor
Cardiff and Vale University Health Board
Phase
Not applicable
Overall status
Completed
Start date
November 27, 2017
Completion date
May 30, 2022
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diastolic heart failure